MSR30 Modelling Monthly Migraine Day Distribution: A Case Study of Fremanezumab Japanese-Korean Clinical Trials for Migraine Prevention

Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.1237
https://www.valueinhealthjournal.com/article/S1098-3015(22)01438-3/fulltext
Title : MSR30 Modelling Monthly Migraine Day Distribution: A Case Study of Fremanezumab Japanese-Korean Clinical Trials for Migraine Prevention
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01438-3&doi=10.1016/j.jval.2022.04.1237
First page :
Section Title :
Open access? : No
Section Order : 11103
Categories :
Tags :
Regions :
ViH Article Tags :